Exploring Treatment Options for Pediatric Growth Hormone Deficiency

Inside the report

1. 01 Treatment landscapedaily and long-acting growth hormone options as prescribers see them
2. 02 Skytrofa in practicephysician satisfaction and where it fits
3. 03 Treatment challengesadherence, injection burden, access and family education
4. 04 Physician needswhat would help treaters manage paediatric GHD better
5. 05 Patient and caregiver factorsthe considerations families raise most
6. 06 Recommendationsimprovements physicians want to see from manufacturers and payers

What this report tells you

Paediatric growth hormone deficiency is a small population with a heavy treatment burden. This report surveys treating physicians on the options available to them, with a focus on Skytrofa and the long-acting shift.

It reports high physician satisfaction alongside the challenges that remain in adherence, access and patient education, and closes with the improvements physicians recommend.

The full report is available on request. Leave your details below and our team will email it to you.